Publication | Open Access

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

T-nhl Cell LinesSignaling PathwayPtcl TreatmentApoptosisImmunologyCell DeathAnti-cancer AgentB ActivityImmunotherapyMedicineCell BiologyCell Signaling